Latest news
HAB Pharmaceuticals & Research Limited Targets ₹3,000 Crore Revenue by 2030 with Manufacturing and GLP-1 Expansion - SMEStreetSMEStreet · Wed, 29 Jul 2026 11:59:37 GMTHAB Pharmaceuticals targets ₹3,000 crore with twin manufacturing push - Manufacturing Today IndiaManufacturing Today India · Wed, 29 Jul 2026 07:00:00 GMTKabelschlepp India spotlights intelligent motion at AMTEX 2026 - Manufacturing Today IndiaManufacturing Today India · Wed, 29 Jul 2026 07:00:00 GMT